JD Health InternationalJDHIF 90 PS Ratio is 1.81 as of Jun. 29, 2026, which is 42% below its 10-year median of 3.10. GuruFocus rates JDHIF with a GF Score™ of 90/100 and a GF Value™ of $10.42. The stock has 1 warning sign investors should review. Among 657 Healthcare Providers & Services companies, JD Health International ranks better than 53.42% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, JD Health International's share price is $5.85.
JD Health International's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $3.23. Hence, JD Health International's PS Ratio for today is 1.81.
Good Sign:
JD Health International Inc stock PS Ratio (=1.26) is close to 1-year low of 1.26.
The historical rank and industry rank for JD Health International's PS Ratio or its related term are showing as below:
JDHIF'
s PS Ratio Range Over the Past 10 Years
Min: 1.11 Med: 3.1 Max: 42.85
Current: 1.27
During the past 9 years, JD Health International's highest PS Ratio was 42.85. The lowest was 1.11. And the median was 3.10.
JDHIF's PS Ratio is ranked better than 53.42% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 1.51
vs JDHIF: 1.27
During the past 9 years, JD Health International's highest 3-Year average Revenue per Share Growth Rate was 70.40% per year. The lowest was 15.20% per year. And the median was 40.55% per year.
Back to Basics: PS Ratio
JD Health International (OTCPK:JDHIF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International PS Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, JD Health International's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JD Health International PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's PS Ratio distribution charts can be found below:
* The bar in red indicates where JD Health International's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
JD Health International's Share Price of today is $5.85.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. JD Health International's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $3.23.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
JD Health International (JDHIF) has a PS Ratio of 1.81 as of Jun. 29, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on JD Health International and its competitors. This is 42% below median its historical median of 3.10. Over the past decade, JD Health International's PS Ratio has ranged from 1.11 to 42.85. According to the industry distribution chart, JD Health International ranks #306 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 46.6%.
Is JD Health International's PS Ratio too high?
JD Health International's current PS Ratio of 1.81 is 42% below median its 10-year median of 3.10. Over the past 10 years, this metric has ranged from a low of 1.11 to a high of 42.85. The Healthcare Providers & Services industry median PS Ratio is 1.51. JD Health International's value of 1.81 is 19.9% above this industry median. Based on the distribution chart, JD Health International ranks #306 out of 657 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, JD Health International has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does JD Health International's PS Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, JD Health International ranks #306 out of 657 companies for PS Ratio. This puts JD Health International in the upper half of its industry. The industry median PS Ratio is 1.51. JD Health International's value of 1.81 is 19.9% above this benchmark. Historically, JD Health International's own PS Ratio has ranged from 1.11 to 42.85 over the past decade. While the company's 10-year median is 3.10 vs. the industry median of 1.51, JD Health International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.51, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JD Health International's current PS Ratio of 1.81 is 19.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on JD Health International and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JD Health International's current PS Ratio is 1.81, which is 42% below median its own 10-year median of 3.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
JD Health International (JDHIF) has a current PS Ratio of 1.81. The stock's GF Value™ is $10.42, compared to a current price of $5.85 — trading 43.9% below its estimated fair value. The current PS Ratio is 1.81, which is 42% below median its 10-year median of 3.10 and 19.9% above the Healthcare Providers & Services industry median of 1.51. JD Health International's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For JD Health International (JDHIF), the current PS Ratio is 1.81 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JD Health International (JDHIF) Overvalued in 2026?
Based on GuruFocus' analysis, JD Health International stock appears to be undervalued.
The current stock price of $5.85 is trading 43.9% below its estimated GF Value™ of $10.42.
Key valuation signals for JDHIF:
PS Ratio: 1.81 (42% below median its 10-year median of 3.10)
GF Value™: $10.42 vs. price of $5.85 (43.9% below fair value)
Industry Position: 19.9% above the Healthcare Providers & Services median (#306 of 657)
No single metric tells the full story. See the JDHIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
90GF Score
Get the complete analysis for JDHIF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JDHIF has been successfully added to your 
